L & S Advisors’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-1,870
| Closed | -$272K | – | 269 |
|
|
2022
Q2 | $272K | Sell |
1,870
-24,064
| -93% | -$3.5M | 0.05% | 193 |
|
|
2022
Q1 | $3.08M | Sell |
25,934
-16,544
| -39% | -$1.96M | 0.36% | 78 |
|
|
2021
Q4 | $5.85M | Sell |
42,478
-11,647
| -22% | -$1.61M | 0.63% | 46 |
|
|
2021
Q3 | $7.52M | Sell |
54,125
-7,669
| -12% | -$1.07M | 0.81% | 30 |
|
|
2021
Q2 | $6M | Buy |
61,794
+2,983
| +5% | +$290K | 0.65% | 38 |
|
|
2021
Q1 | $4.02M | Sell |
58,811
-1,465
| -2% | -$100K | 0.46% | 72 |
|
|
2020
Q4 | $5.17M | Sell |
60,276
-2,284
| -4% | -$196K | 0.6% | 50 |
|
|
2020
Q3 | $4.07M | Sell |
62,560
-6,003
| -9% | -$390K | 0.56% | 64 |
|
|
2020
Q2 | $5.01M | Sell |
68,563
-44,688
| -39% | -$3.27M | 0.75% | 41 |
|
|
2020
Q1 | $3.85M | Buy |
113,251
+47,718
| +73% | +$1.62M | 0.73% | 30 |
|
|
2019
Q4 | $3.57M | Buy |
65,533
+5,407
| +9% | +$294K | 0.46% | 55 |
|
|
2019
Q3 | $2.51M | Sell |
60,126
-21,742
| -27% | -$907K | 0.35% | 86 |
|
|
2019
Q2 | $3.59M | Buy |
81,868
+39,446
| +93% | +$1.73M | 0.47% | 60 |
|
|
2019
Q1 | $2.18M | Sell |
42,422
-1,718
| -4% | -$88.4K | 0.29% | 84 |
|
|
2018
Q4 | $1.63M | Buy |
44,140
+17,625
| +66% | +$652K | 0.31% | 63 |
|
|
2018
Q3 | $996K | Buy |
26,515
+5,830
| +28% | +$219K | 0.13% | 144 |
|
|
2018
Q2 | $817K | Buy |
+20,685
| New | +$817K | 0.14% | 151 |
|